Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Lyra Therapeutics Inc (LYRA)

Lyra Therapeutics Inc (LYRA)
0.1044 +0.0053 (+5.35%) 12:53 ET [NASDAQ]
0.1041 x 600 0.1044 x 900
Realtime by (Cboe BZX)
0.1041 x 600 0.1044 x 900
Realtime 0.1008 +0.0017 (-) 09:28 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Lyra Therapeutics Inc 480 ARSENAL STREET WATERTOWN MA 02472 USA

https://lyratherapeutics.com Employees: 30 P: 617-393-4600

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Lyra Therapeutics Inc. is a clinical-stage therapeutics company. It is focused on the development and commercialization of novel integrated drug and delivery solutions for patients with ear, nose and throat diseases. The company's proprietary technology platform, XTreo(TM), is designed to precisely and consistently deliver medicines directly to the affected tissue. Its initial product candidates consist LYR-210 and LYR-220 which are in clinical stage. Lyra Therapeutics Inc. is based in Watertown, Mass.

Key Statistics

Overview:

Market Capitalization, $K 6,529
Enterprise Value, $K -34,051
Shares Outstanding, K 65,881
Annual Sales, $ 1,530 K
Annual Net Income, $ -93,440 K
Last Quarter Sales, $ 210 K
Last Quarter Net Income, $ -10,980 K
EBIT, $ -96,340 K
EBITDA, $ -98,150 K
60-Month Beta 0.04
% of Insider Shareholders 3.25%
% of Institutional Shareholders 95.62%
Float, K 63,740
% Float 96.75%
Short Volume Ratio 0.29

Growth:

1-Year Return -97.98%
3-Year Return -98.25%
5-Year Return -99.47%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 03/13/25
Next Earnings Date 04/29/25 [--]
Earnings Per Share ttm -0.98
EPS Growth vs. Prev Qtr 11.11%
EPS Growth vs. Prev Year 27.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LYRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -182.38%
Return-on-Assets % -67.31%
Profit Margin % -6,107.19%
Debt/Equity 0.00
Price/Sales 3.98
Price/Cash Flow N/A
Price/Book 0.52
Book Value/Share 0.18
Interest Coverage -0.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective